JPH03842B2 - - Google Patents
Info
- Publication number
- JPH03842B2 JPH03842B2 JP60191262A JP19126285A JPH03842B2 JP H03842 B2 JPH03842 B2 JP H03842B2 JP 60191262 A JP60191262 A JP 60191262A JP 19126285 A JP19126285 A JP 19126285A JP H03842 B2 JPH03842 B2 JP H03842B2
- Authority
- JP
- Japan
- Prior art keywords
- hours
- group
- compound
- acid
- yield
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 241000700605 Viruses Species 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 9
- 125000003118 aryl group Chemical group 0.000 claims description 5
- 230000000415 inactivating effect Effects 0.000 claims description 4
- 125000001624 naphthyl group Chemical group 0.000 claims description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 125000004432 carbon atom Chemical group C* 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 230000000937 inactivator Effects 0.000 claims description 2
- 125000002483 aldosyl group Chemical group 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 27
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 21
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 21
- 150000001875 compounds Chemical class 0.000 description 21
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 15
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 239000002904 solvent Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 11
- -1 aryl isocyanate Chemical class 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000010898 silica gel chromatography Methods 0.000 description 8
- 238000000338 in vitro Methods 0.000 description 7
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 7
- 239000011347 resin Substances 0.000 description 7
- 229920005989 resin Polymers 0.000 description 7
- 150000001323 aldoses Chemical class 0.000 description 6
- 239000007864 aqueous solution Substances 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 150000007523 nucleic acids Chemical class 0.000 description 6
- 102000039446 nucleic acids Human genes 0.000 description 6
- 108020004707 nucleic acids Proteins 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000003786 synthesis reaction Methods 0.000 description 6
- 239000006188 syrup Substances 0.000 description 6
- 235000020357 syrup Nutrition 0.000 description 6
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 5
- PYMYPHUHKUWMLA-LMVFSUKVSA-N aldehydo-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229910052760 oxygen Inorganic materials 0.000 description 5
- 239000001301 oxygen Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- BDQNKCYCTYYMAA-UHFFFAOYSA-N 1-isocyanatonaphthalene Chemical compound C1=CC=C2C(N=C=O)=CC=CC2=C1 BDQNKCYCTYYMAA-UHFFFAOYSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 4
- 238000010992 reflux Methods 0.000 description 4
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical group O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- 241000723873 Tobacco mosaic virus Species 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000005755 formation reaction Methods 0.000 description 3
- 229950002441 glucurolactone Drugs 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- 239000012948 isocyanate Substances 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- DGTNSSLYPYDJGL-UHFFFAOYSA-N phenyl isocyanate Chemical compound O=C=NC1=CC=CC=C1 DGTNSSLYPYDJGL-UHFFFAOYSA-N 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000035484 reaction time Effects 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 238000006359 acetalization reaction Methods 0.000 description 2
- IAJILQKETJEXLJ-QTBDOELSSA-N aldehydo-D-glucuronic acid Chemical compound O=C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-QTBDOELSSA-N 0.000 description 2
- HXBPYFMVGFDZFT-UHFFFAOYSA-N allyl isocyanate Chemical compound C=CCN=C=O HXBPYFMVGFDZFT-UHFFFAOYSA-N 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 150000001491 aromatic compounds Chemical class 0.000 description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- 239000003480 eluent Substances 0.000 description 2
- 229940097043 glucuronic acid Drugs 0.000 description 2
- MNQZXJOMYWMBOU-UHFFFAOYSA-N glyceraldehyde Chemical group OCC(O)C=O MNQZXJOMYWMBOU-UHFFFAOYSA-N 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 150000002513 isocyanates Chemical class 0.000 description 2
- 238000007273 lactonization reaction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 125000001209 o-nitrophenyl group Chemical group [H]C1=C([H])C(*)=C(C([H])=C1[H])[N+]([O-])=O 0.000 description 2
- 125000000636 p-nitrophenyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1*)[N+]([O-])=O 0.000 description 2
- 125000006239 protecting group Chemical group 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 230000007017 scission Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- XDIYNQZUNSSENW-UUBOPVPUSA-N (2R,3S,4R,5R)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O XDIYNQZUNSSENW-UUBOPVPUSA-N 0.000 description 1
- KEJGAYKWRDILTF-VVULQXIFSA-N (3ar,5s,6r,6ar)-5-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-ol Chemical compound O1C(C)(C)OC[C@@H]1[C@@H]1[C@@H](O)[C@H]2OC(C)(C)O[C@H]2O1 KEJGAYKWRDILTF-VVULQXIFSA-N 0.000 description 1
- KEJGAYKWRDILTF-JDDHQFAOSA-N (3ar,5s,6s,6ar)-5-[(4r)-2,2-dimethyl-1,3-dioxolan-4-yl]-2,2-dimethyl-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]dioxol-6-ol Chemical compound O1C(C)(C)OC[C@@H]1[C@@H]1[C@H](O)[C@H]2OC(C)(C)O[C@H]2O1 KEJGAYKWRDILTF-JDDHQFAOSA-N 0.000 description 1
- 102000018832 Cytochromes Human genes 0.000 description 1
- 108010052832 Cytochromes Proteins 0.000 description 1
- WQZGKKKJIJFFOK-IVMDWMLBSA-N D-allopyranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@H](O)[C@@H]1O WQZGKKKJIJFFOK-IVMDWMLBSA-N 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 241000702315 Escherichia virus phiX174 Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 150000001312 aldohexoses Chemical class 0.000 description 1
- 150000001322 aldose derivatives Chemical class 0.000 description 1
- 150000001338 aliphatic hydrocarbons Chemical class 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- AVVWPBAENSWJCB-UKFBFLRUSA-N alpha-D-glucofuranose Chemical compound OC[C@@H](O)[C@H]1O[C@H](O)[C@H](O)[C@H]1O AVVWPBAENSWJCB-UKFBFLRUSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- 150000001555 benzenes Chemical class 0.000 description 1
- MDHYEMXUFSJLGV-UHFFFAOYSA-N beta-phenethyl acetate Natural products CC(=O)OCCC1=CC=CC=C1 MDHYEMXUFSJLGV-UHFFFAOYSA-N 0.000 description 1
- 230000002252 carbamoylating effect Effects 0.000 description 1
- 230000021235 carbamoylation Effects 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229920001429 chelating resin Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000006266 etherification reaction Methods 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002402 hexoses Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- KPXFIETUTLCJAC-UHFFFAOYSA-N isocyanic acid;naphthalene Chemical compound N=C=O.C1=CC=CC2=CC=CC=C21 KPXFIETUTLCJAC-UHFFFAOYSA-N 0.000 description 1
- 125000000654 isopropylidene group Chemical group C(C)(C)=* 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 150000002972 pentoses Chemical class 0.000 description 1
- 150000002978 peroxides Chemical class 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 150000003138 primary alcohols Chemical group 0.000 description 1
- OVARTBFNCCXQKS-UHFFFAOYSA-N propan-2-one;hydrate Chemical compound O.CC(C)=O OVARTBFNCCXQKS-UHFFFAOYSA-N 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 241001515965 unidentified phage Species 0.000 description 1
Landscapes
- Agricultural Chemicals And Associated Chemicals (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
【発明の詳細な説明】
本発明は植物のウイルスの不活化能を有するア
ルドース誘導体に関する。DETAILED DESCRIPTION OF THE INVENTION The present invention relates to aldose derivatives having the ability to inactivate plant viruses.
さらに詳しくは植物のウイルスの不活化能を有
するO−アリールカルバモイル基だ置換されたア
ルドース又はその誘導体に関する。 More specifically, the present invention relates to an aldose substituted with an O -arylcarbamoyl group or a derivative thereof having the ability to inactivate plant viruses.
近年ウイルス不活化剤として核酸を切断する化
合物に関する研究が盛んとなり、これまでに簡単
な化合物としては過酸化物、キノン、メルカプタ
ンなどが提案されているが、未だ充分な効果を挙
げるには至つていない。 In recent years, research into compounds that cleave nucleic acids as virus inactivators has become active, and simple compounds such as peroxides, quinones, and mercaptans have been proposed, but they are still far from being fully effective. Not yet.
本発明者らは、ウイルスの本体を形成する核酸
が酸素ラジカルによつて切断されることに着目し
て酸素ラジカル生成能を有する化合物として、そ
れ自体には酸素ラジカル生成能を有しないアルド
ースを基本化合物としてその誘導体につき鋭意研
究を行い、核酸切断作用を有する、すなわちウイ
ルス不活化能を有する、新規な誘導体を見出し、
本発明に至つた。 The present inventors focused on the fact that the nucleic acids that form the main body of the virus are cleaved by oxygen radicals, and developed aldose, which itself does not have the ability to generate oxygen radicals, as a compound that has the ability to generate oxygen radicals. We conducted intensive research on its derivatives as compounds and discovered a new derivative that has the ability to cleave nucleic acids, that is, it has the ability to inactivate viruses.
This led to the present invention.
即ち、本発明は、アリール基がフエニル基又は
ナフチル基であるO−アリールカルバモイルアル
ドース又はO−アリールカルバモイルアルドウロ
ン酸を有効成分とする植物用ウイルス不活化剤を
要旨とするものである。 That is, the gist of the present invention is a virus inactivating agent for plants containing as an active ingredient O -arylcarbamoylaldose or O -arylcarbamoylaldouronic acid in which the aryl group is a phenyl group or a naphthyl group.
この誘導体は酸素ラジカル生成能を有し、また
インヴイトロ(in vitro)で核酸切断作用を示す
ことが明らかとなつた。 It has been revealed that this derivative has the ability to generate oxygen radicals and also exhibits a nucleic acid cleaving action in vitro.
更にこの誘導体のタバコモザイクウイルス及び
バクテリオフアージφ×174に対する不活化作用
をインヴイトロで検査し、有効であることが明ら
かとなつた。 Furthermore, the inactivating effect of this derivative on tobacco mosaic virus and bacteriophage φ×174 was tested in vitro, and it was found to be effective.
本発明におけるO−アリールカルバモイルアル
ドースのアルドース部又はO−カルバモイルアル
ドウロン酸のアルドウロン酸部の主鎖の炭素数は
5又は6であることが好ましい。 In the present invention, the number of carbon atoms in the main chain of the aldose moiety of O -arylcarbamoylaldose or the aldouronic acid moiety of O -carbamoylalduronic acid is preferably 5 or 6.
本発明におけるO−アリールカルバモイルアル
ドース又はO−アリールカルバモイルアルドウロ
ン酸を例えば5炭糖について式示すれば次のよう
である。但し本式は、フイツシヤーの式示による
ものではない。 The formula of O -arylcarbamoylaldose or O -arylcarbamoylaldouronic acid in the present invention, for example, for pentose is as follows. However, this formula is not based on Fischer's formula.
ここにR1,R2及びR3はOH又は−OCO−NH
−Aを表わし、R4は−CH2OH,−COOH又は−
CH2−OCO−NH−Aを表わし、R1からR4迄は
全体として少なくとも1つの−OCO−NH−Aを
含み、Aはアリール基を表わす。このアリール基
Aの例としてはフエニル基、ナフチル基(それら
のベンゼン核上のHが置換された基を含む)を挙
げることができる。 Here R 1 , R 2 and R 3 are OH or -OCO-NH
-A, R 4 is -CH 2 OH, -COOH or -
It represents CH 2 --OCO-NH-A, R 1 to R 4 as a whole contain at least one --OCO-NH-A, and A represents an aryl group. Examples of the aryl group A include a phenyl group and a naphthyl group (including groups in which H on the benzene nucleus thereof is substituted).
また例えば6炭糖について式示すれば次のよう
である。但し本式はフイツシヤーの式示によるも
のではない。 For example, the formula for hexose is as follows. However, this formula is not based on Fischer's formula.
ここにR5、R6、R7及びR8はOH又は−OCO−
NH−Aを表わし、R9は−CH2H,−COOH又は
−CH2−OCO−NH−Aを表わし、R5からR9ま
では全体として少なくとも1つの−OCO−NH−
Aを含みAは上記のものを同じ意味を表わす。 Here R 5 , R 6 , R 7 and R 8 are OH or -OCO-
NH-A, R 9 represents -CH 2 H, -COOH or -CH 2 -OCO-NH-A, and R 5 to R 9 collectively represent at least one -OCO-NH-
Contains A, where A has the same meaning as above.
本発明におけるO−アリールカルバモイルアル
ドースを合成するには適当な溶媒中でアルドース
又はアルドウロン酸にアリルイソシアネートを反
応させることにより達することができる。 The O -arylcarbamoyl aldose of the present invention can be synthesized by reacting aldose or alduronic acid with allyl isocyanate in a suitable solvent.
アルドースの特定の部位をカルバモイル化する
場合には、まずカルバモイル化すべき部位の水酸
基を定め、その他の反応性水酸基を保護し、
適当な溶媒中でアリルイソシアネートを反応さ
せ、保護された生成物を分取し、保護基を離
脱させ、ついで生成物を分離、精製する。 When carbamoylating a specific site of an aldose, first determine the hydroxyl group at the site to be carbamoylated, protect other reactive hydroxyl groups,
Allyl isocyanate is reacted in a suitable solvent, the protected product is separated, the protecting group is removed, and the product is then separated and purified.
カルバモイル化を望まない水酸基の保護の目的
にはエーテル化、アセタール化、エステル化、分
子内ラクトン化などのいずれも使用可能である
が、アセタール化時にイソプロピリデンアセター
ル化(アセトニド化)、分子内ラクトン化が取扱
い上有利であり、また後続のシリカゲルクロマト
グラフイー処理に対して安定であるという利点が
ある。但し分子内ラクトン化はグルクロン酸のよ
うなアルドースの一級アルコール部分の酸化物の
場合のみ可能である。 Etherification, acetalization, esterification, intramolecular lactonization, etc. can all be used to protect hydroxyl groups where carbamoylation is not desired, but isopropylidene acetalization (acetonidation) and intramolecular lactone formation are It has the advantage of being convenient for handling and being stable against subsequent silica gel chromatography treatment. However, intramolecular lactonization is possible only in the case of oxides of the primary alcohol moiety of aldoses, such as glucuronic acid.
アリールイソシアネートとしてはフエニルイソ
シアネート、ナフタレンイソシアネートおよびそ
の核置換誘導体を用いることができる。前記核置
換誘導体の核置換基としてはp−ニトロフエニル
基、m−ニトロフエニル基、o−ニトロフエニル
基、p−,m−又はo−ニトロナフチル基、p
−,m−,又はo−ハロゲノフエニル基、p−,
m−又はo−ハロゲノナフチル基を挙げることが
できる。 As the aryl isocyanate, phenyl isocyanate, naphthalene isocyanate, and nuclear substituted derivatives thereof can be used. The nuclear substituents of the nuclear substituted derivatives include p-nitrophenyl group, m-nitrophenyl group, o-nitrophenyl group, p-, m- or o-nitronaphthyl group, p-nitrophenyl group, m-nitrophenyl group, o-nitrophenyl group,
-, m-, or o-halogenophenyl group, p-,
Mention may be made of the m- or o-halogenonaphthyl group.
イソシアネートによるカルバメート化における
溶媒としてはカルバメート化反応に無為の溶媒で
あれば何でも使用可能であり、脂肪族炭化水素、
脂環族炭化水素、芳香族炭化水素、ピリジン等の
塩基性芳香族化合物を用いることができる。特に
前記塩基性芳香族化合物では反応時間を短縮し得
て有利である。 As the solvent for carbamate formation with isocyanate, any solvent can be used as long as it has no effect on the carbamate reaction, including aliphatic hydrocarbons,
Basic aromatic compounds such as alicyclic hydrocarbons, aromatic hydrocarbons, and pyridine can be used. In particular, the above-mentioned basic aromatic compounds are advantageous because the reaction time can be shortened.
前記溶媒中におけるアルドース又はアルドウロ
ン酸(保護されたものを含む)の濃度は1〜
5g/100mlの範囲が好ましい。アリールイソシア
ネートの濃度は前記アルドース又はアルドウロン
酸に対して1.5〜2.0モル当量の範囲が好ましい。 The concentration of aldose or alduronic acid (including protected ones) in the solvent is from 1 to
A range of 5g/100ml is preferred. The concentration of the arylisocyanate is preferably in the range of 1.5 to 2.0 molar equivalents relative to the aldose or alduronic acid.
前記カルバメート化反応は前記イソシアネート
がこわれないようにするため乾燥した雰囲気中で
行なうのが好ましい。空気雰囲気化で行なつても
よいが、N2のような不活性ガス中で行なうのが
好ましい。 The carbamate formation reaction is preferably carried out in a dry atmosphere to prevent the isocyanate from being destroyed. Although it may be carried out in an air atmosphere, it is preferably carried out in an inert gas such as N 2 .
前記カルバメート化反応の温度は約10℃から溶
媒の沸点付近までにおいて行いうる。 The carbamate reaction can be carried out at a temperature of about 10° C. to around the boiling point of the solvent.
前記カルバメート化反応の圧力は常圧で行うこ
とができるが、溶媒が蒸発しない範囲での減圧下
で、又は加圧下に行つてもよい。 The carbamate-forming reaction can be carried out at normal pressure, but it may also be carried out under reduced pressure or under increased pressure as long as the solvent does not evaporate.
前記カルバメート化反応の時間は1時間以上24
時間程度とすることができるが、収率及び副反応
抑制の観点から5〜15時間程度が好ましい。 The carbamate reaction time is 1 hour or more24
The reaction time can be about 1 hour, but from the viewpoint of yield and suppression of side reactions, about 5 to 15 hours is preferable.
保護された反応生成物の分離については、該反
応生成物の沸点が一般に高く、蒸留によつては分
解するおそれがあつて分離し難いのでクロマトグ
ラフイーによつて分取するのが好ましい。このク
ロマトグラフイーの充填剤としてはシリカゲル、
アルミナ等の無機物又は多糖類を用いうるが、シ
リカゲルを用いるのが効率的である。溶出剤とし
ては芳香族炭化水素とエステルとの混合系が適当
である。特にベンゼン−酢酸エチル系混合物が優
れている。 Regarding the separation of the protected reaction product, it is preferable to separate it by chromatography because the reaction product generally has a high boiling point and is difficult to separate due to the risk of decomposition by distillation. The packing material for this chromatography is silica gel,
Although inorganic substances such as alumina or polysaccharides can be used, it is efficient to use silica gel. A mixed system of an aromatic hydrocarbon and an ester is suitable as the eluent. In particular, a benzene-ethyl acetate mixture is excellent.
保護基の脱離法としては、一般にジオキサン−
塩酸混液、60%酢酸、イオン交換樹脂等を用いう
るが、イオン交換樹脂の存在下においてアセトン
−水混合液で処理するのが適当である。 Generally speaking, dioxane-
Although a hydrochloric acid mixture, 60% acetic acid, an ion exchange resin, etc. can be used, it is appropriate to treat with an acetone-water mixture in the presence of an ion exchange resin.
保護基を脱した生成物は前述の如くシリカゲル
クロマトグラフイーで分取、精製するのが好まし
い。溶出剤としては極性溶剤とアルコール類との
組合わせが適当であるが、特にクロロホルム−メ
タノール混合物が効率よく用いることができる。 The product from which the protecting group has been removed is preferably separated and purified by silica gel chromatography as described above. As the eluent, a combination of a polar solvent and an alcohol is suitable, but a chloroform-methanol mixture can be used particularly efficiently.
以下に実施例を示すが、本発明はこれらに限ら
れるものではない。 Examples are shown below, but the present invention is not limited thereto.
参考例 1
〔3−O−フエニルカルバモイル−D−グルコ
ース(1)の合成〕
1,2,5,6−ジ−O−イソプロピリデン−
α−D−グルコフラノース(7.0g)、無水ピリジ
ン(30ml)、フエニルイソシアネート(14ml)を
撹拌しながら、室温で15時間反応させた後、溶媒
と過剰の試薬を留去し、生成物をさらにシリカゲ
ルカラムクロマトグラフイーにかけ、ベンゼン:
酢酸エチル(20:1V/V)混液で溶出を行い、
TLCでRF0.45(ベンゼン:酢酸エチル,5:1V/
V)を示す1,2,5,6−ジ−O−イソプロピ
リデン−3−O−フエニルカルバモイル−α−D
−グルコフラノース(シラツプ;〔α〕D+6lo;
νmax3300、2980、1730cm-1)を98%の収量で得
た。この化合物(5g)を10%アセトン水溶液
(100ml)にとかし、アンバーライト(商標)
IR120B(H+)(強酸性イオン交換樹脂;H+型)
(以下IR120B(H+)」と略記する。)(3g)を加え、
95℃、5時間撹拌した後、樹脂をろ過し、ろ液を
減圧濃縮して得られたシロツプをシリカゲルカラ
ムクロマトグラフイー(クロロホルム:メタノー
ル,20:1V/V)にかけ、TLC(クロロホルム:
メタノール,6:1V/V)0.22の画分を集め、
減圧濃縮し、結晶性の目的物〔1〕を79%で得
た。Reference example 1 [Synthesis of 3- O -phenylcarbamoyl-D-glucose (1)] 1,2,5,6-di- O -isopropylidene-
After reacting α-D-glucofuranose (7.0 g), anhydrous pyridine (30 ml), and phenyl isocyanate (14 ml) at room temperature for 15 hours with stirring, the solvent and excess reagent were distilled off, and the product was recovered. Furthermore, it was subjected to silica gel column chromatography, and benzene:
Elution was performed with a mixture of ethyl acetate (20:1 V/V),
R F 0.45 (benzene:ethyl acetate, 5:1V/
V) 1,2,5,6-di- O -isopropylidene-3- O -phenylcarbamoyl-α-D
−Glucofuranose (Silup; [α] D +6l o ;
νmax 3300, 2980, 1730 cm -1 ) were obtained with a yield of 98%. Dissolve this compound (5 g) in a 10% acetone aqueous solution (100 ml) and use Amberlite (trademark).
IR120B (H + ) (strongly acidic ion exchange resin; H + type)
(hereinafter abbreviated as “IR120B(H + )”) (3g),
After stirring at 95°C for 5 hours, the resin was filtered, the filtrate was concentrated under reduced pressure, and the resulting syrup was subjected to silica gel column chromatography (chloroform:methanol, 20:1 V/V) and TLC (chloroform: methanol, 20:1 V/V).
Methanol, 6:1V/V) 0.22 fractions were collected,
Concentration under reduced pressure yielded the crystalline target product [1] in 79%.
m.p.:110〜120℃
〔α〕D:+19.6゜〜+12.5゜
νmax〔cm-1〕:3500、2900、1720
PMR(CDCl3)δ(ppm):5.9(H−l)
6.25(H−3)
7.5(芳香族H)
UVλmax:193nm(ε7450)
232nm(ε1320)
元素分析(C13H17O7N):
計算値(%) 実測値(%)
N 4.51 4.68
参考例 2
〔3−O−(α−ナフチルカルバモイル)−D−
グルコース()の合成〕
1,2,5,6−ジ−O−イソプロピリデン−
α−D−グルコフラノース(6.5g)、無水ピリジ
ン(40ml)、α−ナフチルイソシアネート(8.2
ml)を光を遮断して室温で5時間撹拌反応させた
後、溶媒を減圧下で留去し、生成したシロツプを
シリカゲルカラムクロマトグラフイー(ベンゼ
ン:酢酸エチル,5:1V/V)により分画精製
し、RF0.55の画分を集め、減圧濃縮を行い、1,
2,5,6−ジ−O−イソプロピデン−3−O−
(α−ナフチルカルバモイル)−α−D−グルコフ
ラノース(シラツプ;〔α〕D+72゜;νmax3300、
2980、1780cm-1;PMR(CDCl3)δ1.2、1.3、1.5、
1.6、5.9、7.5ppm)を96%の収量で得た。この化
合物(4g)を10%アセトン水溶液100mlにけんだ
くし、IR120B(H+)(3g)を加え、97℃,10時間
撹拌処理し、樹脂をろ過後ろ液を減圧下で濃縮
し、シリカゲルクロマトグラフイーでRF0.21(ク
ロロホルム:メタノール,6:1V/V)を示す
分画を集め、目的物を82%の収量で得た。 mp: 110~120℃ [α] D : +19.6°~+12.5° νmax [cm -1 ]: 3500, 2900, 1720 PMR (CDCl 3 ) δ (ppm): 5.9 (H-l) 6.25 ( H-3) 7.5 (Aromatic H) UVλmax: 193nm (ε7450) 232nm (ε1320) Elemental analysis (C 13 H 17 O 7 N): Calculated value (%) Actual value (%) N 4.51 4.68 Reference example 2 [3 -O- (α-naphthylcarbamoyl)-D-
Synthesis of glucose ()] 1,2,5,6-di- O -isopropylidene-
α-D-glucofuranose (6.5g), anhydrous pyridine (40ml), α-naphthyl isocyanate (8.2
ml) was reacted with stirring at room temperature for 5 hours in the absence of light, the solvent was distilled off under reduced pressure, and the resulting syrup was separated by silica gel column chromatography (benzene: ethyl acetate, 5:1 V/V). The fractions with R F 0.55 were collected, concentrated under reduced pressure, and 1.
2,5,6-di- O -isopropiden-3- O-
(α-naphthylcarbamoyl)-α-D-glucofuranose (silap; [α] D +72°; νmax3300,
2980, 1780cm -1 ; PMR (CDCl 3 ) δ1.2, 1.3, 1.5,
1.6, 5.9, 7.5ppm) were obtained in 96% yield. This compound (4 g) was suspended in 100 ml of 10% acetone aqueous solution, IR120B (H + ) (3 g) was added, stirred at 97℃ for 10 hours, the resin was filtered, the liquid was concentrated under reduced pressure, and chromatographed on silica gel. Fractions showing R F 0.21 (chloroform:methanol, 6:1 V/V) by graphie were collected, and the desired product was obtained in a yield of 82%.
m.p.:196〜198℃
〔αD〕〕:+13.5゜〜+11.2゜
νmax〔cm-1〕:3500、1720
PMR(DMSO)δ(ppm):4,68、5.21、
7.5UVλmax:222nm(ε45700)、287nm(
(ε4850)
元素分析(C17H19O7N):
計算値(%) 実測値(%)
N 3.95 3.99
参考例 3
〔3−O−(α−ナフチルカルバモイル)−D−
アロース()の合成〕
1,2,5,6−ジ−O−イソプロピリデン−
α−D−アロフラノース(6.5g)、無水ピリジン
(40ml)、α−ナフチルイソシアネート(8.2ml)
を光を遮断して室温10時間撹拌反応させた後、溶
媒を減圧下で留去し、生成したシラツプをシリカ
ゲルクロマトグラフイー(ベンゼン:酢酸エチ
ル,5:1V/V)により分画精製し、RF0.39の
画分を集め、減圧濃縮を行い、1,2,5,6−
ジ−O−イソプロピリデン−3−O−(α−ナフ
チルカルバモイル)−α−D−アロフラノース
(シラツプ;〔α〕D+71.4゜;νmax3300,2980,
1780cm-1;PMR(CDCl3)δ1.2、1.3、1.5、1.6、
5.9、7.5ppm)を97%の収量で得た。この化合物
(4g)を10%アセトン水溶液100mlにけんだくし、
IR120B(H+)(3g)を加え、85℃、5時間撹拌処
理し、樹脂をろ過後ろ液を減圧下で濃縮し、シリ
カゲルクロマトグラフイーでRF0.27(クロロホル
ム:メタノール,6:1V/V)を示す分画を集
め、目的物を60%の収量で得た。 mp: 196 to 198℃ [α D ]: +13.5° to +11.2° νmax [cm -1 ]: 3500, 1720 PMR (DMSO) δ (ppm): 4, 68, 5.21,
7.5UVλmax: 222nm (ε45700), 287nm ((ε4850) Elemental analysis (C 17 H 19 O 7 N): Calculated value (%) Actual value (%) N 3.95 3.99 Reference example 3 [3- O - (α-naphthyl carbamoyl)-D-
Synthesis of allose ()] 1,2,5,6-di- O -isopropylidene-
α-D-Allofuranose (6.5g), anhydrous pyridine (40ml), α-naphthylisocyanate (8.2ml)
After reacting with stirring at room temperature for 10 hours while shielding from light, the solvent was distilled off under reduced pressure, and the resulting syrup was fractionated and purified by silica gel chromatography (benzene: ethyl acetate, 5:1 V/V). Fractions with R F 0.39 were collected, concentrated under reduced pressure, and 1,2,5,6-
Di- O -isopropylidene-3- O- (α-naphthylcarbamoyl)-α-D-allofuranose (silap; [α] D +71.4°; νmax3300, 2980,
1780cm -1 ; PMR (CDCl 3 ) δ1.2, 1.3, 1.5, 1.6,
5.9, 7.5ppm) with a yield of 97%. This compound (4 g) was suspended in 100 ml of 10% acetone aqueous solution,
Add IR120B (H + ) (3 g), stir at 85°C for 5 hours, filter the resin, concentrate the liquid under reduced pressure, and perform silica gel chromatography to R F 0.27 (chloroform:methanol, 6:1V/V). ), and the desired product was obtained with a yield of 60%.
m.p.:89〜91℃
〔αD〕:+8.2゜〜3.3゜
νmax〔cm-1〕:3500、1720
PMR(DMSO−d6)δ(ppm):4.68、5.22、7.5
元素分析(C17H19O7N):
計算値(%) 実測値(%)
N 3.99 3.99
参考例 4
〔5−O−(α−ナフチルカルバモイル)−D−
グルクロン酸()の合成〕
3,6−D−グルクロノラクトン(10g)を
400mlの無水アセトンに加温溶解し、IR120B
(H+)(6g)を加え、15時間還流加熱した。反応
後、IR120B(H+)をろ別し、濃縮し、クロロホ
ルムで抽出し、これを減圧留去しシロツプを少量
の酢酸エチルに溶かしてヘキサンを加えて結晶化
を行い、1,2−O−イソプロピリデン−3,6
−D−グルクロノラクトン(m.p.120〜121℃;
〔α〕D+7.0゜;νmax3380、1770cm-1)を50%の収
量で得た。この化合物(3,3g)とα−ナフチ
ルイソシアネート(6.5ml)を無水ピリジン(40
ml)にとかし、光を遮断して6時間反応させ減圧
留去してシラツプを得、メタノールから結晶化し
て1,2−O−イソプロピリデン−5−O−(α
−ナフチルカルバモイル)−3,6−D−グルク
ロノラクトン(m.p.174〜176℃;νmax3420、
1800、1720cm-1;PMR(CDCl3)δ7.8、5,2、
5.1、4.9、1.5、1.3ppm;〔α〕D+75゜)を80%の収
量で得た。この化合物(3g)を10%アセトン水
溶液にけんだくし、IR120B(H+)(1g)を加え80
℃で24時間加水分解し反応後樹脂をろ別し、脱色
炭処理後、減圧濃縮し、生成物を熱酢酸エチルか
ら結晶化して5−O−(α−ナフチルカルバモイ
ル)−D−グルクロン酸を80%の収量で得た。 mp: 89 to 91℃ [α D ]: +8.2° to 3.3° νmax [cm -1 ]: 3500, 1720 PMR (DMSO−d 6 ) δ (ppm): 4.68, 5.22, 7.5 Elemental analysis (C 17 H 19 O 7 N): Calculated value (%) Actual value (%) N 3.99 3.99 Reference example 4 [5- O -(α-naphthylcarbamoyl)-D-
Synthesis of glucuronic acid ()] 3,6-D-glucuronolactone (10g)
Dissolve IR120B in 400ml of anhydrous acetone by heating.
(H + ) (6 g) was added and heated under reflux for 15 hours. After the reaction, IR120B (H + ) was filtered off, concentrated, and extracted with chloroform. This was distilled off under reduced pressure. The syrup was dissolved in a small amount of ethyl acetate, and hexane was added to crystallize it . -isopropylidene-3,6
-D-glucuronolactone (mp120-121℃;
[α] D +7.0°; νmax 3380, 1770 cm -1 ) was obtained with a yield of 50%. This compound (3.3g) and α-naphthylisocyanate (6.5ml) were mixed with anhydrous pyridine (40%
ml), reacted for 6 hours in the dark and distilled under reduced pressure to obtain a syrup, which was crystallized from methanol to give 1,2- O -isopropylidene-5- O- (α
-naphthylcarbamoyl)-3,6-D-glucuronolactone (mp174-176℃; νmax3420,
1800, 1720cm -1 ; PMR (CDCl 3 ) δ7.8, 5, 2,
5.1, 4.9, 1.5, 1.3 ppm; [α] D +75°) were obtained in 80% yield. This compound (3g) was suspended in a 10% acetone aqueous solution, and IR120B (H + ) (1g) was added to it for 80 minutes.
After hydrolysis at ℃ for 24 hours, the resin was filtered off, treated with decolorizing charcoal, concentrated under reduced pressure, and the product was crystallized from hot ethyl acetate to obtain 5- O- (α-naphthylcarbamoyl)-D-glucuronic acid. Obtained with a yield of 80%.
m.p.:189〜190℃
〔αD〕:−25゜〜−7.5゜
νmax(cm-1):3480、1730
PMR(DMSO−d6)δ(ppm):8.1、7.6、5.6
参考例 5
〔5−O−フエニルカルバモイル−D−リボー
ス(v)の合成〕
D−リボース(10g)、無水アセトン−無水メ
タノール混合物(1/1、V/V)76ml、
IR120B(H+)(5g)を2時間還流加熱反応させ
た。樹脂をろ別し、ろ液を減圧濃縮しシラツプを
得た。さらに、クロロホルムで抽出精製してメチ
ル2,3−O−イソプロピリデン−β−D−リボ
シドを60%の収量で得た。この化合物1gとフエ
ニルイソシアネート2.5mlとを30mlのピリジン中、
室温で10時間撹拌しながら反応させ、溶媒を留去
後、シリカゲルクロマトグラフイー(ベンゼン:
酢酸エチル;5:lV/V)でRF0.65の画分を集
め、98%の収量でメチル2,6−O−イソプロピ
リデン−5−O−フエニルカルバモイル−β−D
−リボフラノシド(〔α〕D−33.6゜;νmax3420、
1700cm-1;PMR(CDCl3)δ7.4、4.9、3.4、1.5、
1.6ppm)を得た。この化合物1gを10%アセトン
水溶液にけんだくし、IR120B(H+)(200mg)を
加え、10時間還流加熱した後、樹脂をろ別し、ろ
液を減圧濃縮し、酢酸エチルから結晶化して、目
的物を80%の収量で得た。 mp: 189 to 190℃ [α D ]: −25° to −7.5° νmax (cm -1 ): 3480, 1730 PMR (DMSO−d 6 ) δ (ppm): 8.1, 7.6, 5.6 Reference example 5 [5 - Synthesis of O -phenylcarbamoyl-D-ribose (v)] D-ribose (10g), 76ml of anhydrous acetone-anhydrous methanol mixture (1/1, V/V),
IR120B (H + ) (5 g) was reacted under reflux for 2 hours. The resin was filtered off, and the filtrate was concentrated under reduced pressure to obtain syrup. Furthermore, the product was extracted and purified with chloroform to obtain methyl 2,3- O -isopropylidene-β-D-riboside in a yield of 60%. 1 g of this compound and 2.5 ml of phenyl isocyanate in 30 ml of pyridine,
The reaction was carried out with stirring at room temperature for 10 hours, and after distilling off the solvent, silica gel chromatography (benzene:
Fractions with R F 0.65 were collected with ethyl acetate; 5:lV/V) to give methyl 2,6- O -isopropylidene-5- O -phenylcarbamoyl-β-D with a yield of 98%.
−ribofuranoside ([α] D −33.6°; νmax3420,
1700cm -1 ; PMR (CDCl 3 ) δ7.4, 4.9, 3.4, 1.5,
1.6ppm). 1 g of this compound was suspended in a 10% acetone aqueous solution, IR120B (H + ) (200 mg) was added, and after heating under reflux for 10 hours, the resin was filtered off, the filtrate was concentrated under reduced pressure, and crystallized from ethyl acetate. , the desired product was obtained in 80% yield.
m.p:106〜107℃
〔αD〕:+20゜〜+26.3゜
νmax(cm-1):3460、3420、3030、1700、1230
PMR(DMSO−d6)δ(ppm):7.4、5.02
元素分析(C12H17NO6):
計算値(%) 実測値(%)
N 5.20 5.30
参考例 6
〔5−O−(α−ナフチルカルバモイル)−D−
リボース()の合成〕
(v)の調製で用いたメチル2,3−O−イソ
プロピリデン−β−D−ロリボフラノシド
(4g)、α−ナフチルイソシアネート(5ml)、ピ
リジン(50ml)を光を遮断して15時間室温で撹拌
した後、溶媒を留去し、シロツプとしてメチル
2,3−O−イソプロピリデン−5−O−(α−
ナフチルカルバモイル)−β−D−リボシド
(νmax3440、1750、1240cm-1;〔α〕D−36.6゜;
PMR(CDCl3)δ7,6、4.98、3.28、1.4、
1.2ppm)を100%の収量で得た。この化合物5gを
10%アセトン水溶液にけんだくし、IR120B(H+)
(2g)を加え、90゜で5時間還流加熱して反応さ
せ、その後、樹脂をろ別し、ろ液を濃縮し、シリ
カゲルカラムクロマトグラフイー(クロロホル
ム:メタノール;10:1V/V)でRF0.35の画分
を精製し、濃縮し、酢酸エチルから結晶化して目
的物を85%の収量で得た。 mp: 106 to 107℃ [α D ]: +20° to +26.3° νmax (cm -1 ): 3460, 3420, 3030, 1700, 1230 PMR (DMSO−d 6 ) δ (ppm): 7.4, 5.02 Element Analysis (C 12 H 17 NO 6 ): Calculated value (%) Actual value (%) N 5.20 5.30 Reference example 6 [5- O -(α-naphthylcarbamoyl)-D-
Synthesis of ribose ()] Methyl 2,3- O -isopropylidene-β-D-loribofuranoside (4 g), α-naphthyl isocyanate (5 ml), and pyridine (50 ml) used in the preparation of (v) were stirred at room temperature for 15 hours in the absence of light. After that, the solvent was distilled off and methyl 2,3- O -isopropylidene-5- O- (α-
naphthylcarbamoyl)-β-D-riboside (νmax3440, 1750, 1240cm -1 ; [α] D -36.6°;
PMR (CDCl 3 ) δ7, 6, 4.98, 3.28, 1.4,
1.2 ppm) was obtained in 100% yield. 5g of this compound
Soak in 10% acetone aqueous solution, IR120B (H + )
(2 g) was added and reacted by heating under reflux at 90° for 5 hours. After that, the resin was filtered off, the filtrate was concentrated, and R The F 0.35 fraction was purified, concentrated, and crystallized from ethyl acetate to obtain the desired product in 85% yield.
m.p.:113〜114℃
〔α〕D:+14.3゜〜+18.6゜
νmax(cm-1):3460、3400、3030 1700
PMR(DMSO−d6)δ(ppm):7.4、5.02、
元素分析(C13H19NO6):
計算値(%) 実測値(%)
N 4.39 4.34
参考例 7
〔化合物〜の酸素ラジカル生成能〕
5×10-5MのチトクロームC溶液(PH8.0,
0.2Mリン酸緩衝液)に化合物〜(10-2M)
を溶解し、直ちに、25℃で550nmの吸光度の増加
を調べたところ、:6.95×10-4;:2.85×
10-4;:6.62×10-4;
:1.44×10-2;v:5.67×10-3;
:3.09×10-3(ΔA550/min)という結果が得
られた。コントロールとして用いたブドウ糖(D
−グルコース),D−リボースはそれぞれ0.75×
10-4および1.5×10-4(20%エタノール溶液)を示
した。 mp: 113~114℃ [α] D : +14.3°~+18.6° νmax (cm -1 ): 3460, 3400, 3030 1700 PMR (DMSO−d 6 ) δ (ppm): 7.4, 5.02, Element Analysis (C 13 H 19 NO 6 ): Calculated value (%) Actual value (%) N 4.39 4.34 Reference example 7 [Oxygen radical generation ability of compound ~] 5 × 10 -5 M cytochrome C solution (PH8.0,
Compound ~(10 -2 M) in 0.2M phosphate buffer)
When dissolved, the increase in absorbance at 550 nm was immediately examined at 25°C, and the result was: 6.95×10 -4 ;: 2.85×
The following results were obtained: 10 -4 ;:6.62×10 -4 ; :1.44×10 -2 ;v:5.67×10 -3 ; :3.09×10 -3 (ΔA550/min). Glucose (D
-glucose) and D-ribose are each 0.75×
10 -4 and 1.5×10 -4 (20% ethanol solution).
参考例 8
〔化合物、およびのインヴイトロ核酸切
断活性〕
化合物、およびをりん酸緩衝液中(PH
7.2)、二重鎖のφ×174DNA200ng、糖lnM、
Cu2+10μMを37℃、3時間処理し、1本鎖の一箇
所切断(Form)および直鎖状DNA(Form)
の生成を調べたところ、それぞれ、18.0%;
86.2、8.4%;84.3、5.8%であつた。Reference Example 8 [In vitro nucleic acid cleavage activity of compound and] Compound and in vitro nucleic acid cleaving activity of compound and
7.2), double-stranded φ×174DNA200ng, sugar lnM,
Treated with Cu 2+ 10μM at 37℃ for 3 hours to cause single strand cleavage (Form) and linear DNA (Form)
When we investigated the generation of , each was 18.0%;
86.2, 8.4%; 84.3, 5.8%.
実施例 1
〔化合物〜のインヴイトロウイルス不活化
作用〕
化合物〜のインヴイトロウイルス不活化作
用を、タバコモザイクウイルスおよびバクテリオ
フアージφ×174を用いて検討した。前者はリン
酸緩衝液(0.2M、PH8.1)中、糖濃度10-2M、
Cu2+10-4Mを用い、37℃、3時間ウイルスと反応
させ、ウイルスの生存率(%)を、N.タパカム
を用いる半葉法で検定を行つた。後者はリン酸緩
衝液中、10-3Mの糖濃度、Cu2+10-6Mでφ×174
を37℃、3時間処理し、処理0時間に対するプラ
ークの生成率を生存率(%)とした。化合物、
、のTMVに対する不活化能は、生存率がそ
れぞれ51、14および60%という結果で示された。
一方、化合物、、はφ×174に対してそれ
ぞれ33.8、38.4、および44.2%を示した。Example 1 [In vitro virus inactivation effect of compound ~] The in vitro virus inactivation effect of compound ~ was investigated using tobacco mosaic virus and bacteriophage φx174. The former has a sugar concentration of 10 -2 M in phosphate buffer (0.2 M, PH8.1),
The virus was reacted with Cu 2+ 10 -4 M at 37° C. for 3 hours, and the survival rate (%) of the virus was assayed by the half-leaf method using N. tapacum. The latter is φ × 174 at a sugar concentration of 10 -3 M and Cu 2+ 10 -6 M in phosphate buffer.
were treated at 37° C. for 3 hours, and the rate of plaque formation relative to 0 hours of treatment was defined as survival rate (%). Compound,
The inactivating ability of TMV was demonstrated by survival rates of 51, 14, and 60%, respectively.
On the other hand, compounds showed 33.8, 38.4, and 44.2% for φ×174, respectively.
以上3つのインヴイトロ反応性および生物活性
の結果(参考例6、7及び実施例1)は、これら
の誘導体が未置換の糖(アルドヘキソース)には
みられない、又は未置換の場合より大きい反応性
又は生物活性を有することを示している。 The above three in vitro reactivity and biological activity results (Reference Examples 6, 7 and Example 1) indicate that these derivatives have a reactivity that is not observed in unsubstituted sugars (aldohexoses) or is greater than in unsubstituted sugars. This indicates that the substance has biological activity or biological activity.
Claims (1)
るO−アリールカルバモイルアルバドース又はO
−アリールカルバモイルアルドウロン酸を有効成
分とする植物用ウイルス不活化剤。 2 アルドース部又はアルドウロン酸部の主鎖の
炭素数が5又は6であることを特徴とする第1項
記載の植物用ウイルス不活化剤。[Scope of Claims] 1 O-arylcarbamoyl albatose or O -arylcarbamoyl albatose in which the aryl group is a phenyl group or a naphthyl group
- A virus inactivator for plants containing arylcarbamoylaldouronic acid as an active ingredient. 2. The virus inactivating agent for plants according to item 1, wherein the main chain of the aldose moiety or the alduronic acid moiety has 5 or 6 carbon atoms.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19126285A JPS6251618A (en) | 1985-08-30 | 1985-08-30 | Virus inactivator |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP19126285A JPS6251618A (en) | 1985-08-30 | 1985-08-30 | Virus inactivator |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS6251618A JPS6251618A (en) | 1987-03-06 |
JPH03842B2 true JPH03842B2 (en) | 1991-01-09 |
Family
ID=16271609
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP19126285A Granted JPS6251618A (en) | 1985-08-30 | 1985-08-30 | Virus inactivator |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS6251618A (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005092907A2 (en) * | 2004-03-26 | 2005-10-06 | Ranbaxy Laboratories Limited | Monosaccharide derivatives as anti-cancer and anti-inflammatory agents |
US20090048186A1 (en) * | 2005-04-19 | 2009-02-19 | Vishwajanani Jitendra Sattigeri | Monosaccharide Derivatives as Anti-Inflammatory and/or Anti-Cancer Agents |
US7790689B2 (en) | 2006-05-30 | 2010-09-07 | Ranbaxy Laboratories Limited | Monosaccharide derivatives |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50117744A (en) * | 1974-03-06 | 1975-09-16 |
-
1985
- 1985-08-30 JP JP19126285A patent/JPS6251618A/en active Granted
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS50117744A (en) * | 1974-03-06 | 1975-09-16 |
Also Published As
Publication number | Publication date |
---|---|
JPS6251618A (en) | 1987-03-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0594291B1 (en) | Processes for the production of 13-ether derivatives of milbemycins, and intermediates therefor | |
Wessel et al. | Acid-catalysed benzylation and allylation by alkyl trichloroacetimidates | |
EP0141057B1 (en) | Novel 4'-demethyl-4-epipodophyllotoxin derivatives, a process for their preparation and their use as medicaments | |
US4056322A (en) | Preparation of ethers of monosaccharides | |
JPH03842B2 (en) | ||
DE3508356C2 (en) | ||
JPS6056994A (en) | Tocopherol derivative | |
EP0204344A2 (en) | Sialosylcerebrosides and a preparation method thereof | |
US3960836A (en) | Acylated derivatives of pyrazofurin and process for their preparation | |
FR2518091A1 (en) | 23-DEHYDRO-25-HYDROXYVITAMINE D3, PROCESS FOR PREPARING THE SAME AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME | |
EP0445021A2 (en) | Tris acyl-2",3",4'ethylidene-4",6"-beta-D-glucopyranosides, their production and use in the synthesis of ethylidene-4",6"-beta-D-glucopyranosides of epipodophyllotoxin | |
JPS585920B2 (en) | L-ascorbic acid derivative | |
DE69509377T2 (en) | ANTHRACYCLINE DERIVATIVES CONTAINING A TRIFLUORMETHYLATED SUGAR UNIT | |
Flowers | Substituted cerebrosides: Part II. Synthetic dihydrosulfatides | |
Desai et al. | The allylation of dibutylstannylene derivatives of myo-inositol | |
EP0773949B1 (en) | D-mannose or xylitol esters and their use as drugs | |
AU712905B2 (en) | High yield stereospecific mannosylation | |
KR960015408B1 (en) | Glucose pyranose derivatives, method of preparation thereof, pharmaceutical compositions containing them | |
DE69323998T2 (en) | PHARMACEUTICAL ACTIVE FLAVILIUM COMPOUNDS | |
EP0226381B1 (en) | Novel glucopyranose derivatives | |
EP0675895A1 (en) | Etoposide derivatives, process for their preparation, their use as a drug and in the preparation of a drug for treating cancer. | |
EP0104631A2 (en) | Clavulone derivatives, process for preparing the same, and use of said compounds | |
FR2688003A1 (en) | Nucleoside derivatives, their preparation and their biological applications | |
US4251515A (en) | Novel nitrosourea derivatives | |
CH623060A5 (en) | Process for the preparation of monosaccharides substituted by an ether functional group |